Showing results (21-30 of 374) with videos related to
Sort By:
Pageof 38
Drug Discovery Today|January 24, 2021
Drugs acting on the renin-angiotensin system and SARS-CoV-2Antonio Vitiello, Chiara Pelliccia, Francesco FerraraInflammopharmacology|February 1, 2023
The direct correlation between microbiota and SARS-CoV-2 infectious diseaseAntonio Vitiello, Francesco Ferrara, Andrea ZoviMedical Hypotheses|January 18, 2021
Scientific hypothesis and rational pharmacological for the use of sacubitril/valsartan in cardiac damage caused by COVID-19Antonio Vitiello, Raffaele La Porta, Francesco FerraraSN Comprehensive Clinical Medicine|August 25, 2020
The Central Role of Clinical Nutrition in COVID-19 Patients During and After Hospitalization in Intensive Care UnitFrancesco Ferrara, Francesco De Rosa, Antonio VitielloCancers|October 27, 2022
Precision Medicine in the Treatment of Locally Advanced or Metastatic Urothelial Cancer: New Molecular Targets and Pharmacological TherapiesAntonio Vitiello, Francesco Ferrara, Ruggero Lasala, et al.Herz|November 4, 2022
Overview of pharmacotherapy targeting COVID-19 disease based on ACE-2: current challenges and future directionsAntonio Vitiello, Andrea Zovi, Ugo Trama, et al.Advanced Pharmaceutical Bulletin|September 13, 2021
Clinical Pharmacology Aspects in Patients Treated with TNF Inhibitors During SARS-Cov-2 PandemicFrancesco Ferrara, Priscilla Santilli, Vilma D'Aiuto, et al.Inflammopharmacology|August 18, 2022
Nirmatrelvir-remdesivir association for non-hospitalized adults with COVID-19, point of viewFrancesco Ferrara, Andrea Zovi, Ugo Trama, et al.International Journal of Molecular Sciences|December 23, 2022
Pharmacological Agents with Antiviral Activity against Monkeypox InfectionAndrea Zovi, Francesco Ferrara, Roberto Langella, et al.Egyptian Liver Journal|November 15, 2021
The risks of liver injury in COVID-19 patients and pharmacological management to reduce or prevent the damage inducedAntonio Vitiello, Raffaele La Porta, Vilma D'Aiuto, et al.Pageof 38